ASCO American Society of Clinical Oncology
- Start Date:
31 May 2024
- End Date:
04 Jun 2024
- Location:
Chicago, IL
- Region:
North America
- Booth #:
10087
Stop by our booth (#10087) to learn how our specialized services can help you advance your oncology drug development with our full spectrum, end-to-end solutions spanning from early drug discovery support and clinical development through market access and commercial strategy:
- Expertise and innovation to help design, plan and execute your early phase oncology clinical trials on time and with quality.
- The latest technology for fast profiling and next generation sequencing of key biomarkers and comprehensive genomic profiling with Oncomine solutions.
- Proven expertise in cell and gene therapy oncology clinical trials, with over 160 immuno-oncology studies and 137 cell and gene therapy trials across tumor types and therapies.
- With rare disease and pediatric expertise across all phases, indications and therapeutic areas — including more than 500 clinical studies — the cross-functional team at our Rare Disease and Pediatrics Center of Excellence delivers innovative, patient-centric solutions to skillfully address the most complex challenges of these trials.
- Laboratory support that combines world-class scientific expertise with industry-leading technologies.
Our specialized capabilities
Visit us at booth #10087 to learn how we can help you meet the complex demands of innovative drug development.
- Recognized as a leader in innovative early phase oncology study designs
- Experts in adaptive trial designs and master protocols
- Proven experience operationalizing adaptive and other innovative trial designs, through our Adaptive Design and Master Protocol Working Group, enables you to unlock better information, faster